000 01277 a2200361 4500
005 20250514024757.0
264 0 _c20020308
008 200203s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/cncr.10292
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJohnson, Timothy K
245 0 0 _aBiokinetics of yttrium-90--labeled huBrE-3 monoclonal antibody.
_h[electronic resource]
260 _bCancer
_cFeb 2002
300 _a1240-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntibodies, Monoclonal
_xpharmacokinetics
650 0 4 _aAntineoplastic Agents
_xpharmacokinetics
650 0 4 _aBreast Neoplasms
_xmetabolism
650 0 4 _aHumans
650 0 4 _aImmunoconjugates
_xpharmacokinetics
650 0 4 _aRadioimmunotherapy
650 0 4 _aWhole-Body Counting
650 0 4 _aYttrium
_xpharmacokinetics
700 1 _aCole, William
700 1 _aQuaife, Robert A
700 1 _aLear, James L
700 1 _aCeriani, Roberto L
700 1 _aJones, Roy B
700 1 _aCagnoni, Pablo J
773 0 _tCancer
_gvol. 94
_gno. 4 Suppl
_gp. 1240-8
856 4 0 _uhttps://doi.org/10.1002/cncr.10292
_zAvailable from publisher's website
999 _c11784890
_d11784890